Cenicriviroc is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target C-C chemokine receptor type 5.
Trade Name |
|
Common Name |
Cenicriviroc |
Indication |
|
Drug Class |
Antivirals; CCR5 antagonists: immunomodulators |